Julien Viotti

548 total citations
15 papers, 256 citations indexed

About

Julien Viotti is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Julien Viotti has authored 15 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Julien Viotti's work include Colorectal and Anal Carcinomas (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Julien Viotti is often cited by papers focused on Colorectal and Anal Carcinomas (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Julien Viotti collaborates with scholars based in France, United States and Monaco. Julien Viotti's co-authors include Frédéric Checler, Olga Corti, Eric Duplan, Cristine Alvès da Costa, Jean Sévalle, Alexis Brice, Hiroyoshi Ariga, Ling Qi, Emilie Giaime and Jean-­Marc Ferrero and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Cell Science and Annals of the Rheumatic Diseases.

In The Last Decade

Julien Viotti

14 papers receiving 253 citations

Peers

Julien Viotti
Johan Willemse Belgium
Jiarong Tang China
Daniel Yeomanson United Kingdom
Sarah Theurer Germany
Coralie Williams United States
David Cheung Canada
Christoph Emontzpohl Germany
Michael J. Zdon United States
Johan Willemse Belgium
Julien Viotti
Citations per year, relative to Julien Viotti Julien Viotti (= 1×) peers Johan Willemse

Countries citing papers authored by Julien Viotti

Since Specialization
Citations

This map shows the geographic impact of Julien Viotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julien Viotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julien Viotti more than expected).

Fields of papers citing papers by Julien Viotti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julien Viotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julien Viotti. The network helps show where Julien Viotti may publish in the future.

Co-authorship network of co-authors of Julien Viotti

This figure shows the co-authorship network connecting the top 25 collaborators of Julien Viotti. A scholar is included among the top collaborators of Julien Viotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julien Viotti. Julien Viotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Guévelou, Jennifer Le, Esma Saâda-Bouzid, Julien Viotti, et al.. (2020). Phase II study of concomitant radiotherapy with atezolizumab in oligometastatic soft tissue sarcomas: STEREOSARC trial protocol. BMJ Open. 10(9). e038391–e038391. 12 indexed citations
2.
Chamorey, Emmanuel, Éric François, Marie‐Christine Etienne, et al.. (2020). DPD status and fluoropyrimidines-based treatment: high activity matters too. BMC Cancer. 20(1). 436–436. 8 indexed citations
3.
Viotti, Julien, Renaud Schiappa, Yann Delpech, et al.. (2020). Relecture préopératoire en sénologie : intérêts et limites d’une validation spécialisée en oncologie. Bulletin du Cancer. 107(3). 295–307.
4.
Montaudié, Henri, Julien Viotti, P. Combemale, et al.. (2020). Cetuximab is efficient and safe in patients with advanced cutaneous squamous cell carcinoma: a retrospective, multicentre study. Oncotarget. 11(4). 378–385. 41 indexed citations
5.
Parassol, Nadège, et al.. (2020). Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio. Journal of Cardiovascular Pharmacology. 76(4). 472–477. 16 indexed citations
6.
Giuliano, Sandy, Maeva Dufies, Papa Diogop Ndiaye, et al.. (2019). Resistance to lysosomotropic drugs used to treat kidney and breast cancers involves autophagy and inflammation and converges in inducing CXCL5. Theranostics. 9(4). 1181–1199. 24 indexed citations
7.
Boussat, Bastien, Olivier François, Julien Viotti, et al.. (2019). Managing Missing Data in the Hospital Survey on Patient Safety Culture: A Simulation Study. Journal of Patient Safety. 17(2). e98–e106. 9 indexed citations
8.
Borchiellini, Delphine, Julien Viotti, Aline Guillot, et al.. (2019). TAXOMET: A French prospective multicenter randomized controlled phase II study comparing docetaxel plus metformin versus docetaxel plus placebo in mCRPC.. Journal of Clinical Oncology. 37(15_suppl). 5004–5004. 9 indexed citations
9.
Culié, Dorian, R. Garrel, Julien Viotti, et al.. (2018). Impact of HPV-associated p16-expression and other clinical factors on therapeutic decision-making in patients with oropharyngeal cancer: A GETTEC multicentric study. European Journal of Surgical Oncology. 44(12). 1908–1913. 8 indexed citations
10.
11.
Gal, Jocelyn, G. Milano, Jean-­Marc Ferrero, et al.. (2017). Optimizing drug development in oncology by clinical trial simulation: Why and how?. Briefings in Bioinformatics. 19(6). 1203–1217. 18 indexed citations
12.
Martin, Nicolas, Delphine Borchiellini, Julien Viotti, et al.. (2017). Impact of pharmacokinetics (PK) of sunitinib (SU) and its metabolite SU12662 on clinical outcome and toxicity in metastatic renal cell cancer (mRCC) patients.. Journal of Clinical Oncology. 35(6_suppl). 506–506. 1 indexed citations
13.
Duplan, Eric, Emilie Giaime, Julien Viotti, et al.. (2013). ER-stress-associated functional link between Parkin and DJ-1 via a transcriptional cascade involving the tumor suppressor p53 and the spliced X-box binding protein XBP-1. Journal of Cell Science. 126(Pt 9). 2124–33. 72 indexed citations
14.
Duplan, Eric, Jean Sévalle, Julien Viotti, et al.. (2013). Parkin differently regulates presenilin-1 and presenilin-2 functions by direct control of their promoter transcription. Journal of Molecular Cell Biology. 5(2). 132–142. 32 indexed citations
15.
Trujillo, E., et al.. (2012). AB0375 Success rates of assisted reproductive techniques in patients with inflammatory rheumatic disease. Annals of the Rheumatic Diseases. 71. 659–659. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johan Willemse Breakdown of academic impact, for papers by Jiarong Tang Breakdown of academic impact, for papers by Daniel Yeomanson Breakdown of academic impact, for papers by Sarah Theurer Breakdown of academic impact, for papers by Coralie Williams Breakdown of academic impact, for papers by David Cheung Breakdown of academic impact, for papers by Christoph Emontzpohl Breakdown of academic impact, for papers by Michael J. Zdon
Rankless by CCL
2026